HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mehdi Mirsaeidi Selected Research

Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2

1/2022Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
1/2021Activity of the growth hormone-releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis-like granuloma.
10/2020Growth Hormone-Releasing Hormone in Lung Physiology and Pulmonary Disease.
10/2019Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mehdi Mirsaeidi Research Topics

Disease

19Sarcoidosis (Schaumann Disease)
01/2022 - 09/2013
14COVID-19
11/2022 - 01/2020
14Infections
11/2022 - 12/2005
11Pulmonary Sarcoidosis
03/2022 - 04/2014
9Inflammation (Inflammations)
08/2022 - 04/2016
5Neoplasms (Cancer)
01/2022 - 09/2014
5Lung Diseases (Lung Disease)
10/2020 - 09/2014
4Granuloma
01/2022 - 10/2014
3Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2022 - 01/2008
3Dyspnea (Shortness of Breath)
10/2021 - 04/2014
3Fibrosis (Cirrhosis)
01/2021 - 10/2019
3Asthma (Bronchial Asthma)
01/2021 - 11/2016
3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2018 - 12/2016
3Tuberculosis (Tuberculoses)
01/2018 - 08/2009
2Respiratory Insufficiency (Respiratory Failure)
06/2022 - 02/2018
2Necrosis
01/2021 - 03/2020
2Lung Injury
10/2020 - 10/2019
2Lung Neoplasms (Lung Cancer)
10/2020 - 11/2016
2Pneumonia (Pneumonitis)
10/2020 - 10/2019
2Chronic Obstructive Pulmonary Disease (COPD)
08/2020 - 11/2016
2Neurosarcoidosis
01/2016 - 09/2013
2Acquired Immunodeficiency Syndrome (AIDS)
09/2014 - 01/2013
1Hypoxia (Hypoxemia)
11/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Disease Progression
10/2021
1Skin Manifestations
01/2021
1Severe Acute Respiratory Syndrome
01/2021
1Insulin Resistance
01/2021
1Cytokine Release Syndrome
10/2020
1Pulmonary Embolism
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
11/2022 - 06/2012
5RNA (Ribonucleic Acid)IBA
08/2022 - 12/2017
5Indicators and Reagents (Reagents)IBA
04/2022 - 01/2018
5CytokinesIBA
03/2022 - 10/2014
5Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2016
4Interleukin-6 (Interleukin 6)IBA
08/2022 - 10/2020
4MicroRNAs (MicroRNA)IBA
08/2022 - 01/2016
4Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
01/2022 - 10/2019
4Pharmaceutical PreparationsIBA
03/2021 - 01/2008
3Peptides (Polypeptides)IBA
03/2022 - 10/2020
3Adrenal Cortex Hormones (Corticosteroids)IBA
03/2022 - 09/2013
3Adrenocorticotropic Hormone (ACTH)FDA Link
03/2022 - 01/2019
3Melanocyte-Stimulating Hormones (MSH)IBA
01/2022 - 01/2019
3Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2014
2Immunologic Factors (Immunomodulators)IBA
03/2022 - 05/2021
2Angiotensin-Converting Enzyme 2IBA
03/2022 - 01/2021
2Oxygen (Dioxygen)IBA
03/2022 - 01/2020
2AntigensIBA
01/2022 - 07/2014
2PyrazinamideFDA LinkGeneric
01/2022 - 03/2017
2Immunoglobulin G (IgG)IBA
10/2021 - 08/2019
2MelanocortinsIBA
01/2021 - 01/2019
2CollagenIBA
01/2021 - 01/2018
2Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
01/2021 - 10/2020
2somatotropin releasing hormone receptorIBA
01/2021 - 10/2019
2Interleukin-7 (Interleukin 7)IBA
01/2021 - 01/2020
2Bleomycin (Blenoxane)FDA LinkGeneric
10/2020 - 10/2019
2Infliximab (Remicade)FDA Link
03/2020 - 04/2014
2Serum AlbuminIBA
01/2020 - 10/2019
2Lactic Acid (Lactate)FDA LinkGeneric
01/2020 - 04/2016
2VaccinesIBA
01/2020 - 07/2014
2ChemokinesIBA
10/2019 - 01/2015
2AnnexinsIBA
12/2016 - 04/2016
2Adalimumab (Humira)FDA Link
10/2014 - 04/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2014 - 08/2009
2Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
09/2014 - 07/2014
1Long Noncoding RNAIBA
08/2022
1MucinsIBA
08/2022
1Transcription Factors (Transcription Factor)IBA
08/2022
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2022
1WastewaterIBA
04/2022
1Complex MixturesIBA
03/2022
1Immunomodulating AgentsIBA
03/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1alpha-MSHIBA
01/2022
1Metformin (Glucophage)FDA LinkGeneric
01/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1Interleukin-12 (IL 12)IBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
01/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2021
1EndotoxinsIBA
01/2021
1Interleukin-2 (IL2)IBA
01/2021
1LigandsIBA
01/2021
1AllergensIBA
01/2021
1Clofazimine (Lamprene)FDA Link
01/2021
1p21-Activated KinasesIBA
10/2020
1NF-kappa B (NF-kB)IBA
10/2020
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2020
1tocilizumab (atlizumab)FDA Link
10/2020
1Particulate MatterIBA
08/2020
1TroponinIBA
01/2020

Therapy/Procedure

12Therapeutics
03/2022 - 09/2013
3Extracorporeal Membrane Oxygenation
09/2016 - 01/2015
2Artificial Respiration (Mechanical Ventilation)
06/2019 - 02/2018
1Pneumonectomy (Lung Volume Reduction)
06/2022
1Mechanical Ventilators (Ventilator)
03/2022
1Length of Stay
01/2021
1Biological Therapy
03/2020